Sign in

CIK 0001613780 · Non-accelerated filer<br>Smaller reporting company

DBV Technologies S.A.

Sign in to watch
Ticker
DBVTF
Exchange
Nasdaq, OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
France
Entity type
operating
Phone
330155427878
Business address
107 AVENUE DE LA REPUBLIQUE, CHATILLON, France

Securities

  • DBVT American Depositary Shares Nasdaq
  • DBVTF Common stock OTC
  1. 4 Derivatives Options or other derivatives
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. SCHEDULE 13D/A Stake Beneficial Ownership Report
  4. SCHEDULE 13D/A Stake Beneficial Ownership Report
  5. SCHEDULE 13D/A Stake Beneficial Ownership Report
  6. 4 Open-market sale Member of 10% owner group sold 3,369,093 shares at an average $4.60 ($15,484,143)
  7. 8-K Event Other events
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership
  10. 4 Open-market sale Chief Medical Officer sold 8,120 shares at an average $2.86 ($23,207)
  11. 4 Grant or award Chief Financial Officer acquired 32,000 shares (grant or award)
  12. 4 Grant or award Chief Commercial Officer acquired 55,000 shares (grant or award)
  13. 4 Derivatives Options or other derivatives
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. 3 Insider Initial Statement of Ownership
  16. SCHEDULE 13D/A Stake Beneficial Ownership Report
  17. 8-K Event Executive or director change · Regulation FD disclosure
  18. 8-K Event Results of operations
  19. 10-Q Report Quarterly Report
  20. SCHEDULE 13G Stake Statement of Beneficial Ownership

Page 3 of 29 · 577 filings